These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30910387)

  • 1. Atherogenic dyslipidemia increases the risk of incident diabetes in statin-treated patients with impaired fasting glucose or obesity.
    Barkas F; Elisaf M; Liberopoulos E; Liamis G; Ntzani EE; Rizos EC
    J Cardiol; 2019 Sep; 74(3):290-295. PubMed ID: 30910387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy with or without ezetimibe and the progression to diabetes.
    Barkas F; Elisaf M; Liberopoulos E; Klouras E; Liamis G; Rizos EC
    J Clin Lipidol; 2016; 10(2):306-13. PubMed ID: 27055961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin diabetogenicity: guidance for clinicians.
    Ray K
    Cardiovasc Diabetol; 2013; 12 Suppl 1(Suppl 1):S3. PubMed ID: 23819776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin Use, Diabetes Incidence and Overall Mortality in Normoglycemic and Impaired Fasting Glucose Patients.
    Castro MR; Simon G; Cha SS; Yawn BP; Melton LJ; Caraballo PJ
    J Gen Intern Med; 2016 May; 31(5):502-8. PubMed ID: 26850412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia.
    Meikle PJ; Wong G; Tan R; Giral P; Robillard P; Orsoni A; Hounslow N; Magliano DJ; Shaw JE; Curran JE; Blangero J; Kingwell BA; Chapman MJ
    J Lipid Res; 2015 Dec; 56(12):2381-92. PubMed ID: 26486974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors associated with atherogenic dyslipidemia in the presence of optimal statin therapy.
    Zhao W; Zheng XL; Jiang ZN; Liao XB; Zhao SP
    Int J Cardiol; 2017 Dec; 248():355-360. PubMed ID: 28689987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of statin use with glycaemic traits and incident type 2 diabetes.
    Ahmadizar F; Ochoa-Rosales C; Glisic M; Franco OH; Muka T; Stricker BH
    Br J Clin Pharmacol; 2019 May; 85(5):993-1002. PubMed ID: 30838685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of impaired fasting glucose, type 2 diabetes and associated risk factors in undiagnosed Chinese rural population: the Henan Rural Cohort Study.
    Abdulai T; Li Y; Zhang H; Tu R; Liu X; Zhang L; Dong X; Li R; Wang Y; Wang C
    BMJ Open; 2019 Aug; 9(8):e029628. PubMed ID: 31383706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of dyslipidemia and atherosclerotic cardiovascular risk in prediabetes.
    Neves JS; Newman C; Bostrom JA; Buysschaert M; Newman JD; Medina JL; Goldberg IJ; Bergman M
    Diabetes Res Clin Pract; 2022 Aug; 190():109980. PubMed ID: 35787415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of rosuvastatin on low-density lipoprotein subfractions in patients with impaired fasting glucose.
    Rizos CV; Kostapanos MS; Rizos EC; Tselepis AD; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2015 May; 20(3):276-83. PubMed ID: 25237153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-course atherogenic blood lipid response to statin discontinuation in dyslipidemic adults.
    Alvarez-Jimenez L; Morales-Palomo F; Moreno-Cabañas A; Mora-Gonzalez D; Turrillas MDCM; Mora-Rodriguez R
    Nutr Metab Cardiovasc Dis; 2024 Oct; 34(10):2334-2343. PubMed ID: 39013748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Obex in Overweight and Obese Subjects With or Without Impaired Fasting Glucose: A Pilot Study.
    Cabrera-Rode E; Rodríguez J; Álvarez A; Echevarría R; Reyes AD; Cubas-Dueñas I; Turcios-Tristá SE; Díaz-Díaz O
    J Diet Suppl; 2017 Nov; 14(6):626-639. PubMed ID: 28384000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid risk factors among elderly with normal fasting glucose, impaired fasting glucose and type 2 diabetes mellitus. The Italian longitudinal study on aging.
    Noale M; Maggi S; Zanoni S; Limongi F; Zambon S; Crepaldi G
    Nutr Metab Cardiovasc Dis; 2013 Mar; 23(3):220-6. PubMed ID: 21937208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline glucose homeostasis predicts the new onset of diabetes during statin therapy: A retrospective study in real life.
    Ponziani MC; Karamouzis I; Mele C; Chasseur L; Zavattaro M; Caputo M; Samà MT; Busti A; Pagano L; Castello L; Marzullo P; Aimaretti G; Prodam F
    Hormones (Athens); 2017 Oct; 16(4):396-404. PubMed ID: 29518760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of alcohol drinking with incident type 2 diabetes and pre-diabetes: The Guangzhou Biobank Cohort Study.
    Li MJ; Ren J; Zhang WS; Jiang CQ; Jin YL; Lam TH; Cheng KK; Thomas GN; Xu L
    Diabetes Metab Res Rev; 2022 Sep; 38(6):e3548. PubMed ID: 35585795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease risk factors in a Nigerian population with impaired fasting blood glucose level and diabetes mellitus.
    Oguoma VM; Nwose EU; Ulasi II; Akintunde AA; Chukwukelu EE; Bwititi PT; Richards RS; Skinner TC
    BMC Public Health; 2017 Jan; 17(1):36. PubMed ID: 28061844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of new-onset diabetes with 1 mg versus 4 mg pitavastatin in patients at high risk of developing diabetes during a 3-year follow-up.
    Jeong HS; Hong SJ; Son S; An H; Kook H; Joo HJ; Park JH; Yu CW; Lim DS
    Cardiovasc Diabetol; 2019 Nov; 18(1):162. PubMed ID: 31752850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study.
    Na E; Cho S; Kim DJ; Choi J; Han E
    Cardiovasc Diabetol; 2020 May; 19(1):67. PubMed ID: 32416728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired fasting glucose and the metabolic profile in Danish children and adolescents with normal weight, overweight, or obesity.
    Kloppenborg JT; Fonvig CE; Nielsen TRH; Mollerup PM; Bøjsøe C; Pedersen O; Johannesen J; Hansen T; Holm JC
    Pediatr Diabetes; 2018 May; 19(3):356-365. PubMed ID: 29193487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins and New-Onset Diabetes Mellitus and Diabetic Complications: A Retrospective Cohort Study of US Healthy Adults.
    Mansi I; Frei CR; Wang CP; Mortensen EM
    J Gen Intern Med; 2015 Nov; 30(11):1599-610. PubMed ID: 25917657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.